Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Subjects with histologically confirmed diagnosis of melanoma with unresectable or metastatic melanoma.
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I